Log in to search using one of your social media accounts:

 

Mayo Clinic Q and A: Proton beam therapy may be recommended for some types of cancer
DEAR MAYO CLINIC: My mother recently was diagnosed with breast cancer, and her doctor told her regular radiation wasn?t as safe as proton beam therapy for her situation. Why would this be the case? I know lots of women who have had radiation for breast cancer treatment. ANSWER: It?s true that standard radiation therapy?often is [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 3, 2017 Category: Databases & Libraries Source Type: news

Adding antiandrogen to radiation therapy improves survival in recurrent prostate cancer
(Massachusetts General Hospital) A nearly two-decades-long clinical trial has demonstrated that adding antiandrogen therapy to radiation therapy can improve the survival of prostate cancer patients who have evidence of disease recurrence after radical prostatectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2017 Category: Cancer & Oncology Source Type: news

Twice-daily radiation therapy cuts deaths from head and neck cancer
(ECCO-the European CanCer Organisation) Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could save more lives. By splitting the daily treatment in two portions, a higher and more effective dose can be given to patients, according to research presented at the European Cancer Congress 2017. The researchers hope that this can be achieved without increasing side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2017 Category: Cancer & Oncology Source Type: news

We've Been Seriously Underestimating Cervical Cancer Risks
Women, especially black women, might face a greater chance of dying of cervical cancer than previously thought, according to a study published Monday in the journal Cancer. Estimates from previous studies may have been artificially low because they included women who had had hysterectomies, a procedure to remove the uterus. The new study suggests that black women are dying at a rate 77 percent higher, and white women are dying at a rate 47 percent higher, than researchers had previously thought. After adjusting for hysterectomies, cervical cancer killed 10 out of every 100,000 black women and approximately 5 out ...
Source: Healthy Living - The Huffington Post - January 24, 2017 Category: Consumer Health News Source Type: news

Unraveling mysteries of pancreatic cancer's resistance to standard therapies
In a new study, researchers have illuminated one of pancreatic cancer's major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive. Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 24, 2017 Category: Science Source Type: news

Penn researchers help unravel mysteries of pancreatic cancer's resistance to standard therapies
(University of Pennsylvania School of Medicine) In a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania have illuminated one of pancreatic cancer's major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive. Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 24, 2017 Category: Cancer & Oncology Source Type: news

SBRT Equivalent to TACE as Bridge to Transplant for Patients With HCC
Use of stereotactic body radiation therapy (SBRT) was equally effective as transarterial chemoembolization (TACE) as a method of bridge to transplant among patients with hepatocellular carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - January 22, 2017 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Conferences/ASCO 2017 Gastrointestinal Cancers Symposium Liver, Gallbladder, and Biliary Tract Cancers News Source Type: news

Surrogate Endpoints Useful in Study of Treatments for Prostate Cancer
In prostate cancer patients, a PSA nadir value of> 0.5 ng/mL after radiation therapy and androgen deprivation therapy can identify patients at a high risk of death. (Source: CancerNetwork)
Source: CancerNetwork - January 21, 2017 Category: Cancer & Oncology Authors: Dave Levitan Tags: Genitourinary Cancers News Prostate Cancer Source Type: news

Many with Advanced Lung Cancer Don't Get Treatments That Might Help
Study found 21 percent went without therapy, even though it could boost their survival Source: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Lung Cancer, Radiation Therapy (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - January 20, 2017 Category: Consumer Health News Source Type: news

Medtec Report: China increases focus on med device development
Regulators in China are looking to promote and increase the localization and development of medical devices in the region and grow the market significantly, according to a report from industry group Medtec. China released its 13th 5-year health strategy plan, drawing a bead on medical devices as a “main breakthrough area” for the country, according to the report. The country is entering a “policy-intensive promotional period,” according to the medtech advocacy group, looking to support the development of high-performance medical equipment including medical imaging devices, advanced radiation th...
Source: Mass Device - January 19, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News MedTech Source Type: news

ViewRay brings in $26m from private placement
ViewRay (NSDQ:VRAY) said today it raised $26.1 million in a private placement of common stock and warrants to support the ongoing commercialization of its MRIdian linear accelerator tech. In the placement, Cleveland-based ViewRay said it sold approximately 8.6 million shares of common stocks with warrants to purchase an additional 1.7 million shares, with an exercise prise of $3.17. The round was led by Puissance Capital Management and joined by existing investors including OrbiMed Advisors, Kearny Venture Partners and new investor Acuta Capital Partners. As part of the placement round, Puissance Capital Management ch...
Source: Mass Device - January 19, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News ViewRay Inc. Source Type: news

TGen identifies compound that could improve drug development against deadly brain cancer
(The Translational Genomics Research Institute) A study led by scientists at TGen has identified 'a potent inhibitory compound' in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer. Aurintricarboxylic Acid (ATA) is a chemical compound that in laboratory tests was shown to block the chemical cascade that otherwise allows glioblastoma cells to invade normal brain tissue and resist both chemo and radiation therapy, according to a TGen-led report published today in the scientific journal Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2017 Category: Cancer & Oncology Source Type: news

Augmenix touts study on prostate treatment
Prostate radiation therapy device developer Augmenix is highlighting the results...Read more on AuntMinnie.comRelated Reading: Augmenix gets FDA clearance for tissue marker (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2017 Category: Radiology Source Type: news

Reducing the radioresistance of cancer
Some cancer cells are protected from radiation therapy through an interaction of interleukin-6 with the Nrf2-antioxidant pathway, researchers have found. The discovery is believed to improve methods of increasing cancer's radiosensitivity. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 13, 2017 Category: Science Source Type: news

Reducing the radioresistance of cancer
(Kumamoto University) Researchers from Kumamoto University in Japan have discovered that some cancer cells are protected from radiation therapy through an interaction of interleukin-6 with the Nrf2-antioxidant pathway. The discovery is believed to improve methods of increasing cancer's radiosensitivity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2017 Category: Cancer & Oncology Source Type: news

Does recent randomized prostate cancer trial provide insights on best treatment?
(Wiley) For the first time, we now have a randomized trial comparing active monitoring, surgery, and radiation therapy for the management of localized prostate cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 12, 2017 Category: Cancer & Oncology Source Type: news

Older lung cancer patients face significant treatment burden
Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according to a new study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 6, 2017 Category: Science Source Type: news

Older lung cancer patients face significant treatment burden
Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according to a study by Yale researchers. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 5, 2017 Category: Universities & Medical Training Tags: Yale News Source Type: news

Older lung cancer patients face significant treatment burden
(Yale University) Depending on the type of treatment older lung cancer patients receive, they can spend an average of one in three days interacting with the healthcare system in the first 60 days after surgery or radiation therapy, according to a study by Yale researchers.The findings are published in current issue of Journal of Oncology Practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 5, 2017 Category: Cancer & Oncology Source Type: news

Cancer authority pulls together the principles, practice and ethics of cancer care
(University of Chicago Medical Center) Selected publications by Samuel Hellman, M.D., former physician-in-chief at the nation's top cancer center, former chair of radiation therapy at the Harvard Medical School and past president of two of the most influential cancer organizations, collected in a new book from Oxford Press. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 4, 2017 Category: Cancer & Oncology Source Type: news

Augmenix touts long-term data for hydrogel spacer in prostate cancer patients
Augmenix Inc. said today that long-term outcomes data from the company’s phase III clinical trial evaluating its hydrogel spacer, SpaceOAR, was published in the International Journal of Radiation Oncology Biology and Physics. The spacer is designed to separate the rectum and prostate during prostate cancer radiotherapy, according to the Waltham, Mass.-based company. The newly published data was collected 3 years after patients were treated with the spacer in the randomized trial. The SpaceOAR is injected as a liquid and then solidifies as a soft hydrogel that pushes the rectum out of the high-dose radiation field dur...
Source: Mass Device - January 3, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Augmenix Inc. Source Type: news

Stockholm County Council, New Karolinska Solna and Elekta Sign Long-term Collaboration Agreement to Advance Cancer Care
STOCKHOLM, Sweden, Dec 30, 2016 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST), Stockholm's County Council and New Karolinska Solna (NKS) have signed a 13-year collaboration agreement which focuses on innovation, joint research, and educa... Devices, Neurosurgery Elekta, radiation therapy, linear accelerator, brachytherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 30, 2016 Category: Pharmaceuticals Source Type: news

Going the Distance: Travel Time ’ s Influence on Radiation Treatment for NH Prostate Cancer Patients
A new Dartmouth study shows that travel time is not a deterrent to radiation therapy for treatment of prostate cancer in New Hampshire. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - December 27, 2016 Category: Hospital Management Authors: Geisel Communications Tags: News cancer Features Norris Cotton Cancer Center radiation therapy Source Type: news

Study provides roadmap to more personalized cancer treatment
Milo Mitchell/UCLA Jonsson Comprehensive Cancer CenterUCLA ’s Dr. Joanne Weidhaas explains her latest research, which could lead to more personalized treatments for head and neck cancer. FINDINGSResearchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.The study was led by UCLA Jonsson Comprehensive Cancer Center member Dr. Joanne Weidhaas in collaboration with colleagues at the NRG Oncology RTOG. ...
Source: UCLA Newsroom: Health Sciences - December 22, 2016 Category: Universities & Medical Training Source Type: news

Histologic classification impacts SBRT treatment in early-stage lung cancer patients
(International Association for the Study of Lung Cancer) Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 22, 2016 Category: Cancer & Oncology Source Type: news

Japan approves Novocure ’ s Optune brain cancer treatment
Novocure (NSDQ:NVCR) said today that the Japanese Ministry of Health, Labor and Welfare has approved its tumor treating fields delivery system, Optune, for adult patients with supra-tentorial glioblastoma following surgery and radiation therapy. The St. Helier, N.J.-based company is expected to submit an application for public reimbursement of the device in Japan for newly diagnosed GBM. Get the full story at our sister site, Drug Delivery Business News. The post Japan approves Novocure’s Optune brain cancer treatment appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Regulatory/Clearance NovoCure Source Type: news

Potentially avoidable breast cancer surgeries cost patients and health-care system
(University of British Columbia Okanagan campus) A recent study by UBC medical researchers examined the health care costs associated with lumpectomy patients requiring reoperations. A lumpectomy, known as breast conservation surgery, is a procedure that removes tumors, aims to conserve breast tissue, and is followed by radiation therapy.The study concluded that with Canadian reoperation rates being more than double recommended targets, the additional cost to BC's health care system alone is $2 million per year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 15, 2016 Category: Cancer & Oncology Source Type: news

New hopes in cancer battle -- a review of new molecules and treatment strategies
(Bentham Science Publishers) Cancer treatment is still one of the most intractable challenge for medicine. There are several approaches to fight cancer, which include: surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy and hormone therapy. From all these treatment methods, chemotherapy seems to be the most widely used. Therefore, it is understandable that scientists are trying to discover new molecules which may be applied as effective chemotherapeutics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 14, 2016 Category: Cancer & Oncology Source Type: news

National cancer group recommends Sirtex ’ s microspheres for metastatic colorectal cancer
Sirtex Medical (ASX:SRX) said yesterday that the National Comprehensive Cancer Network has recommended the company’s radioactive microspheres in its Clinical Practice Guidelines in Oncology for colon cancer and rectal cancer. The NCCN panel uniformly agreed that selective internal radiation therapy with yttrium-90 microspheres is an option for patients with metastatic, chemotherapy resistant colorectal cancer. The recommendation was supported by the More retrospective analysis study, which included 600 patients with colorectal cancer. The data suggested that selective internal radiation therapy using Y-90 m...
Source: Mass Device - December 13, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Oncology Sirtex Medical Source Type: news

Karmanos Nurse Pamela Laszewski to receive prestigious 2017 Oncology Nursing Society Excellence in Radiation Therapy Nursing Award
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - December 12, 2016 Category: Cancer & Oncology Source Type: news

Postmastectomy Implants? Radiotherapy Affects Outcomes Postmastectomy Implants? Radiotherapy Affects Outcomes
Women who received postmastectomy radiation therapy experienced higher complication rates if they had implant reconstruction compared with autologous reconstruction, according to the Mastectomy Reconstruction Outcomes Consortium study.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 9, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

SABCS: RT complicates breast implant reconstruction
Radiation therapy (RT) may increase complications in breast cancer patients...Read more on AuntMinnie.comRelated Reading: Use MRI to diagnose PIP breast implant ruptures, Dutch say MRI adds to cancer detection in women with breast implants Unusual breast implant sensations while flying: Mystery solved Radiotherapy complicates implant-based breast reconstruction FDA OKs new silicone gel-filled breast implant (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2016 Category: Radiology Source Type: news

More complications, less satisfaction in breast cancer patients who get radiation, implants
(University of Michigan Health System) A new study finds that breast cancer patients who have implant reconstruction following radiation therapy had more complications from the surgery and were less satisfied with the result than women who had implants but no radiation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2016 Category: Cancer & Oncology Source Type: news

Radiation therapy may increase complications in breast cancer patients receiving implants
(American Association for Cancer Research) Radiotherapy increased complications and impaired patient-reported satisfaction with reconstructed breasts in breast cancer patients who received implant reconstruction but not in those who received autologous reconstruction, according to data from a large, prospective, multicenter cohort study presented at the 2016 San Antonio Breast Cancer Symposium, held Dec. 6-10. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 8, 2016 Category: Cancer & Oncology Source Type: news

Radiation that knocks electrons out and down, one after another
Researchers are investigating novel ways by which electrons are knocked out of matter. Their research could have implications for radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 7, 2016 Category: Science Source Type: news

DeKalb Medical names new CEO, lays off 60 workers
DeKalb Medical named Bob Wilson its new CEO. He replaces John Shelton, who resigned. Wilson chaired the DeKalb Medical Foundation's board for the last 14 years, helping raise millions of dollars for the health system, which recently updated its Comprehensive Breast Center and expanded its cancer center's radiation therapy program. DeKalb M edical also laid off 60 workers several weeks ago. Part of its woes could be be because it is one of few metro health systems that hasn't announced a possible… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 1, 2016 Category: Biotechnology Authors: Ellie Hensley Source Type: news

Galera adds $15m for Series B
Galera Therapeutics said today that it landed $15 million for its severe oral mucositis treatment, bringing its Series B financing total to $57 million. Sofinnova Ventures led the round, joining existing investors New Enterprise Associates, Novartis Venture Fund, Novo Ventures, Correlation Ventures, Enso Ventures and Galera Angels. The Malvern, Penn.-based company said the proceeds will be used to prepare its lead candidate for phase III registration studies. The treatment, GC4419, is in a randomized, placebo-controlled phase IIb clinical trial to study its impact on severe oral mucositis in head and neck cancer patie...
Source: Mass Device - November 28, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Biotech Clinical Trials Drug-Device Combinations Funding Roundup Oncology Pharmaceuticals Galera Therapeutics Source Type: news

DITTA releases cybersecurity white paper
The Global Diagnostic Imaging, Healthcare IT, and Radiation Therapy Trade Association...Read more on AuntMinnie.comRelated Reading: DITTA endorses refurbishment standards JIRA begins 2-year chairmanship of DITTA Imaging groups form global organization COCIR, JIRA, and MITA collaborate (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 22, 2016 Category: Radiology Source Type: news

Indications for Adjuvant Radiation Therapy in Breast Cancer Indications for Adjuvant Radiation Therapy in Breast Cancer
What is the evidence for adjuvant radiotherapy for different types of breast cancer?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 21, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

CARTI Losses Bring Worry, Advice for Financial Cure Inside New Center
CARTI already was experiencing operating losses before it opened its $88 million cancer center in west Little Rock last November. In the months since then, Central Arkansas Radiation Therapy Institute Inc. has seen its operating losses widen to $20.5 million over the last three fiscal years and missed a financial benchmark for its $49 million bond, which forced it to hire a management consulting firm. Whether it is back on track remains to be seen. CARTI President and CEO Jan Burford recently told Arkansas Business that she is concerned because in the first quarter of its fiscal year that began July 1, the outpatient cance...
Source: Arkansas Business - Health Care - November 21, 2016 Category: American Health Source Type: news

New Interest in Local Therapy for Metastatic Prostate Cancer New Interest in Local Therapy for Metastatic Prostate Cancer
A new study has prostate cancer specialists taking another look at the addition of radiation therapy to primary therapy in metastatic prostate cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 11, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Siemens plans to spin off healthcare as separate business
German industrial giant Siemens is planning to spin off its Siemens Healthineers...Read more on AuntMinnie.comRelated Reading: Siemens installs 1st Somatom Drive CT scanner in U.S. SyntheticMR, Siemens collaborate on MRI scanners IBM Watson unites with Siemens in population health play Siemens to launch CT for radiation therapy at ASTRO Siemens brings new ultrasound systems to CanadaComments: 11/10/2016 2:45:01 PMwoodruGL Siemens has been in the process of dumping Healthcare for many years since they had the rub with the Feds regarding taking folks to dinner etc years ago.  They dumped their I.T. offerings...
Source: AuntMinnie.com Headlines - November 10, 2016 Category: Radiology Source Type: news

Augmenix scores reimbursement code for SpaceOar
Augmenix said today it won a category 1 current procedural terminology reimbursement code from the American Medical Association for periprostatic implantation of biodegradable material, covering its flagship SpaceOAR device. The SpaceOar is designed to separate the prostate from the rectal wall during radiation treatment for prostate cancer, Augmenix said. The device is delivered through a small needle as a liquid, which then solidifies into a soft gel that expands the space between the prostate and rectum during radiotherapy. The substance then liquefies and is absorbed and cleared from the body in the patient&r...
Source: Mass Device - November 9, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Urology Augmenix Inc. Source Type: news

Suppressing protein alleviates radiation-induced bone loss in animal model
New research may hold a clue to curtailing the feared side effect of cancer patients receiving radiation therapy being at high risk of losing bone density and suffering from broken bones within the radiation field during their lifetimes. Suppressing a bone specific protein via its neutralizing antibody alleviates radiation-induced bone loss in an animal model. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 7, 2016 Category: Science Source Type: news

Suppressing protein alleviates radiation-induced bone loss in animal model
(University of Pennsylvania School of Medicine) New research may hold a clue to curtailing the feared side effect of cancer patients receiving radiation therapy being at high risk of losing bone density and suffering from broken bones within the radiation field during their lifetimes. Suppressing a bone specific protein via its neutralizing antibody alleviates radiation-induced bone loss in an animal model. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 7, 2016 Category: Global & Universal Source Type: news

International Celebration Spotlights Breast Imaging Advances
Washington, DC— On Tuesday, Nov. 8, more than 140 medical societies worldwide will mark theInternational Day of Radiology (IDoR), celebrating the thousands of lives saved by the many contributions of breast imagers and radiation oncologists.IDoR 2016 will spotlight breast imaging and the essential role that radiology plays in the detection, diagnosis and management of breast disease. This special day, commemorating the 121st anniversary of the discovery of the X-ray by German physicist Wilhelm Roentgen, is sponsored by theAmerican College of Radiology (ACR),Radiological Society of North America (RSNA) andEuropean Soc...
Source: American College of Radiology - November 1, 2016 Category: Radiology Source Type: news

SyntheticMR, Siemens collaborate on MRI scanners
Swedish medical imaging software developer SyntheticMR has teamed up with Siemens...Read more on AuntMinnie.comRelated Reading: IBM Watson unites with Siemens in population health play Siemens taps customer services executive Siemens to launch CT for radiation therapy at ASTRO SyntheticMR teams with Philips SyntheticMR teams with MD Anderson SyntheticMR signs Cincinnati Children's (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 31, 2016 Category: Radiology Source Type: news

Penn study shows how some intestinal cells resist chemotherapy and radiation
(University of Pennsylvania) When treating cancer with chemotherapy and radiation, decisions about dose must walk a fine line between attacking cancerous cells and preserving healthy ones. Overly aggressive radiation therapy to the torso, for example, can damage the epithelial cells that line the intestines, leading to chronic gastrointestinal problems. A new study from the University of Pennsylvania now shows how some intestinal cells can withstand chemotherapy and radiation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 31, 2016 Category: Global & Universal Source Type: news

Report: Voice box prostheses may only last three months
(Reuters) – Tracheoesophageal voice prosthetic devices often last less than 3 months before they need to be replaced, which is a shorter lifespan than previously reported, according to a new study. “In an ideal setting, voice prostheses should last at least six months and even more ideally, up to one year,” said lead author Jan S. Lewin of The University of Texas MD Anderson Cancer Center in Houston. “In reality, they generally last somewhere about three months before they have to be replaced.” The silicone devices are placed in the shared wall between the trachea and the esophagus after ...
Source: Mass Device - October 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: Clinical Trials Implants Otolaryngology Ear, Nose & Throat Source Type: news

Shortened RT works for low-risk prostate cancer patients
A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk...Read more on AuntMinnie.comRelated Reading: ASTRO: PET predicts outcomes in vulvar cancer patients ASTRO: Radiation boost cuts local recurrence in DCIS patients ASTRO: Negative PET/CT doesn't always mean dormant NSCLC ASTRO: Prostate cancer has 3 molecular subtypes ASTRO: OK to cut RT dose for primary medulloblastoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 4, 2016 Category: Radiology Source Type: news